InsidersTradesSigma
CERNER Corp: directors' dealings · United States · SEC (Form 4)
SEC:cerner-corpUS·SEC (Form 4)Healthcare & Pharma
Explore the full management transaction log of CERNER Corp, a listed issuer based in United States. Shares are quoted on US US, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, CERNER Corp has logged 89 public disclosures. The latest transaction was disclosed on 9 June 2022 — U. Among the most active insiders: Dalton Travis. All data is free.
89
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
€2m
5 ops.
Sell Volume
Financial data
Last declaration on 9 June 2022
Declarations89 total
Executives●U19SEC
€245,7892,768 shares@ €88.7965100.0% of flow
Common Stock
SEC:0001209191-22-035498:0·
Executives●U11SEC
€74,944844 shares@ €88.79653.6% of flow
Common Stock
SEC:0001209191-22-035502:0·
Executives●U19SEC
€554,6236,246 shares@ €88.7965100.0% of flow
Common Stock
SEC:0001209191-22-035508:0·
Executives●U12SEC
€47,861539 shares@ €88.79658.4% of flow
Common Stock
SEC:0001209191-22-035488:0·
Executives●U19SEC
€3m37,460 shares@ €88.7965100.0% of flow
Common Stock
SEC:0001209191-22-035491:0·
Executives●U27SEC
€4m43,905 shares@ €88.7965100.0% of flow
Common Stock
SEC:0001209191-22-035493:0·
Executives●U19SEC
€2m21,909 shares@ €88.7965100.0% of flow
Common Stock
SEC:0001209191-22-035500:0·
Executives●U19SEC
€1m12,825 shares@ €88.7965100.0% of flow
Common Stock
SEC:0001209191-22-035503:0·
Executives●U11SEC
€32,944371 shares@ €88.79654.9% of flow
Common Stock
SEC:0001209191-22-035484:0·
Executives●U19SEC
€2m23,438 shares@ €88.7965100.0% of flow
Common Stock
SEC:0001209191-22-035499:0·
Executives●U11SEC
€26,195295 shares@ €88.79651.9% of flow
Common Stock
SEC:0001209191-22-035492:0·
Executives●U19SEC
€2m26,588 shares@ €88.7965100.0% of flow
Common Stock
SEC:0001209191-22-035504:0·
Executives●U19SEC
€1m15,032 shares@ €88.7965100.0% of flow
Common Stock
SEC:0001209191-22-035497:0·
Executives●U19SEC
€1m14,525 shares@ €88.7965100.0% of flow
Common Stock
SEC:0001209191-22-035501:0·
Executives●U30SEC
€3m31,319 shares@ €88.7965100.0% of flow
Common Stock
SEC:0001209191-22-035495:0·
Executives●X13SEC
€104,9472,000 shares@ €52.473615.8% of flow
Common Stock
SEC:0001209191-22-027636:0·
Executives◇Options11SEC
01,729 shares0
Common Stock
SEC:0001209191-22-026575:0·
Executives▼Sale14SEC
€658,8247,769 shares@ €84.801631.8% of flow
Common Stock
SEC:0001209191-22-018181:0·
Executives●X17SEC
€911,37115,000 shares@ €60.758164.7% of flow
Common Stock
SEC:0001209191-22-017043:0·
Executives◇Options14SEC
07,374 shares0
Common Stock
SEC:0001209191-21-071600·
Executives◇Options22SEC
07,374 shares0
Common Stock
SEC:0001209191-21-071600:0·
Executives◇Options9SEC
04,509 shares0
Common Stock
SEC:0001209191-21-070948·
Executives◇Options9SEC
04,509 shares0
Common Stock
SEC:0001209191-21-070941·
Executives◇Options13SEC
04,407 shares0
Common Stock
SEC:0001209191-21-070953·
Executives◇Options9SEC
011,480 shares0
Common Stock
SEC:0001209191-21-070954·
25 of 89 declarations
About CERNER Corp
Recent developments are dominated by post-acquisition integration rather than standalone corporate actions. Oracle has been repositioning the Cerner asset base under the Oracle Health banner, with a focus on cloud modernization, AI-enabled clinical tools, and tighter integration with Oracle’s broader data and application stack. In practical terms, that means Cerner’s former strategic themes—EHR modernization, workflow automation, interoperability, and hospital digitization—now sit inside Oracle’s healthcare strategy rather than a separate public company. As a result, SEC Form 4 insider-trading activity is associated with Oracle, not Cerner as an independent issuer. For French, Belgian, and Swiss investors, Cerner is best viewed as a historically important U.S. healthcare software franchise that has been folded into a much larger NASDAQ-listed parent, rather than as a separately traded stock.
